参芪地黄汤加减治疗慢性肾脏病的临床疗效分析

Clinical efficacy of the Shenqi Dihuang decoction on chronic kidney disease

目的:探究参芪地黄汤加减治疗慢性肾脏病的临床疗效。方法选取在我院行慢性肾病治疗的患者62例,作为研究对象,根据入院治疗时间的先后,分为常规组(31例)和干预组(31例),常规组给予一般治疗,干预组在一般治疗基础上增加参芪地黄汤加减治疗,对比两组患者治疗有效率、尿蛋白定量与肾功能,进行统计学分析。结果:干预组患者的治疗有效率(83.87%)明显高于常规组患者(61.29%),差异明显,有统计学意义(P<0.05)。治疗后,干预组患者的血肌酐与血尿素氮均低于常规组患者,差异明显,具有统计学意义(P<0.05)。干预组患者的腰膝酸软与常规组相比,具有可比性(P>0.05);干预组患者的恶心呕吐、肢体沉痛、食少纳呆,均低于常规组患者,差异明显,有统计学意义(P<0.05)。结论:对慢性肾脏病患者使用参芪地黄汤加减治疗可有效提高治疗效果,降低血肌酐与血尿素氮,改善肝功能,缓解不良反应,具有显著的治疗效果,值得临床推广及使用。

Objective: To explore the clinical effect of the Shenqi Dihuang decoction (参芪地黄汤) on chronic kidney disease. Methods: 62 patients were divided into the normal group and the intervention group, 31 cases in each group. The normal group took conventional treatment. The intervention group was given the Shenqi Dihuang decoction more. Results: Efficiency in the intervention group was 83.87%, significantly higher than 61.29% in the normal group. Creatinine and urea in the interventional group were lower than the normal group (P<0.05). The nausea and vomiting, limb pain and food loss were lower than the normal group (P<0.05). Conclusion: The Shenqi Dihuang decoction was effective on chronic kidney disease, by reducing creatinine and urea nitrogen, improving liver function and alleviating adverse reactions.